3,4-diarylchromans for inhibiting calmodulin activity

Details 3,4-diarylchromans for inhibiting calmodulin activity 3,4-diarylchromans for inhibiting calmodulin activity

1994-04-17

1996-01-02

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514456, A61K 3135, A61K 3140

Patent

active

054809037

ABSTRACT:
A method for inhibiting is disclosed comprising administering, 3,4-diarylchromans and their pharmaceutically acceptable salts.

REFERENCES:
Veigl et al., Pharmac. Ther. 44:181-239, 1989.
Misra et al., Int. J. Cancer: 43, 781-783 (1989).
MacNeil et al., Br. J. Dermatology, 128, 143-150, 1993.
Barrera et al., Biochemical Pharmacology, 35(17), pp. 2984-2986, 1986.

Affiliated with

Also associated with

Rating

3,4-diarylchromans for inhibiting calmodulin activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3,4-diarylchromans for inhibiting calmodulin activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,4-diarylchromans for inhibiting calmodulin activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-235502